Related Articles

• Study on the infusion‑site adverse events and vascular distribution of epirubicin in chemotherapy with epirubicin and fosaprepitant
• Infusion site adverse events in breast cancer patients receiving highly emetic chemotherapy with prophylactic anti‑emetic treatment with aprepitant and fosaprepitant: A retrospective comparison
• A facile adenosine triphosphate‑responsive nanoplatform for efficacious therapy of esophageal cancer
• Fibroblast activation protein in osteosarcoma cells promotes angiogenesis via AKT and ERK signaling pathways
• Synergistic induction of apoptosis by mapatumumab and anthracyclines in human bladder cancer cells